inSoma Bio Analysis: $3M Raised
What is inSoma Bio?
inSoma Bio develops bio-inspired products for reconstructive plastic surgery, using patients' own tissues instead of synthetic materials for implants and fillers.
Product Features & Capabilities
- Fractomer Biomatrix, bio-inspired solutions for reconstructive plastic surgery, utilizes a person's own tissue instead of synthetic implants, provides support, shape, and biointegration for co-injected cells or tissues, features a thermal switch activated at body temperature, designed at the genetic
How much inSoma Bio raised
s: - $2.5 million
November 1st, 2023Lead Investor: Not specified
Who are the founders of inSoma Bio
SR
AC
Ashutosh Chilkoti
Chairman
Market Focus
inSoma Bio primarily focuses on the medical industry, specifically in the field of reconstructive plastic surgery. They develop bio-inspired solutions that utilize a person's own tissue instead of synthetic implants and fillers.
Business Model
Revenue generated through sales of Fractomer products to medical institutions and surgeons.
Investors
- Duke Capital Partners (Houston)
- Duke Innovation and Entrepreneurship
- FemHealth Ventures
- MedBlue Incubator
- Wallace H.
- Y Combinator
- America's Seed Fund
- Oriza Ventures
- CAV Angels
- North Carolina Biotechnology Center
Competitors Overview
inSoma Bio operates in the reconstructive plastic surgery market, focusing on bio-inspired solutions that utilize a patient's own tissue instead of synthetic implants. Its main competitors include:
- Silk Biomed: This company specializes in neuroregenerative biomaterials, which may offer advan
See something that needs updating? Suggest edits to this profile.